Tetramisole hydrochloride
SIGMA/T1512 - phosphatase inhibitor
Synonym: (±)
CAS Number: 5086-74-8
Empirical Formula (Hill Notation): C11H12N2S · HCl
Molecular Weight: 240.75
EC Number: 225-799-5
MDL Number: MFCD00005536
Linear Formula: C11H12N2S · HCl
Product Type: Chemical
| assay | ≥99% (TLC) |
| biological source | synthetic (organic) |
| description | alkaline phosphatase inhibitor |
| form | powder |
| InChI | 1S/C11H12N2S.ClH/c1-2-4-9 |
| InChI key | LAZPBGZRMVRFKY-UHFFFAOYSA |
| mp | 266-267 °C (lit.) |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].C1CN2CC(N=C2S1)c3cc |
| solubility | water: 50 mg/mL, clear, colorless |
| Application: | Structure-activity relationship for tetramisole derivatives as alkaline phosphatase inhibitors. |
| Application: | Suitable for inhibition of various mammalian alkaline phosphatases (i.e., liver, kidney, placenta, bone and tumor). Intestinal alkaline phosphatases are only slightly inhibited. |
| Other Notes: | Racemic form of levamisole. |
| Packaging: | 2, 5, 10 g in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥99% (TLC) |
| mp | 266-267 °C (lit.) |
| UNSPSC | 12352202 |


